CD44 and neoplasm: Our results confirmed the spatial proximity of multiple sets of ligands and receptors, such as ANXA1‐FPR1, APP‐CD74, MIF‐(CD74 + CD44), and CD99‐CD99, and they basically correspond to the location of tumor cells, myeloid cells, and T cells, respectively (Figure S5).